Lenangio 5mg Capsule 10s
MRP: ₹632.00
Packaging
1 CAP
Composition
Lenalidomide 5mg
Company
Dr. Reddy
MRP: ₹632.00
Packaging
1 CAP
Composition
Lenalidomide 5mg
Company
Dr. Reddy
| Medicine | Company | Price | You Save |
|---|---|---|---|
| Lenmid 5 mg Capsule 10s | CIPLA | ₹1,000.00 | — |
| Lenzest 5mg Capsule 10s | Sun Pharma | ₹1,443.60 | — |
| Lenalid 5mg Cap 30s | Natco Pharma | ₹4,386.00 | — |
HTN, diarrhoea, upper respiratory tract infections, thrombocytopenia, leukopenia, pancytopenia, agranulocytosis, headache, alopecia, dry skin, eczema, erythema multiforme, hypokalaemia, weight loss, asthenia, anxiety, paraesthesia, synovitis, joint disorder, peripheral neuropathy, mild hyperlipidaemia, interstitial lung disease, vasculitis. Potentially Fatal: Hepatotoxicity, sepsis, Stevens-Johnson syndrome, toxic epidermal necrolysis, pancreatitis.
Cholestyramine and activated charcoal may decrease plasma concentration of active metabolite. Concurrent use of methotrexate and other hepatotoxic drugs may increase the risk of hepatotoxicity. Rifampicin increases serum levels of the active metabolite. Potentially Fatal: May enhance the adverse effects of live vaccines.
Hepatic impairment, moderate and severe renal impairment, compromised immune function including bone marrow dysplasia or severe uncontrolled infection, severe hypoproteinaemia; concurrent vaccination w/ live vaccines. Pregnancy and lactation.
Leflunomide is an immunomodulating agent and DMARD. It inhibits pyrimidine synthesis by inhibiting dihydroorotate dehydrogenase enzyme activity resulting in antiproliferative and anti-inflammatory effects. Absorption: Bioavailability: Approx 82-95%. Time to peak plasma concentration (active metabolite): 6-12 hr. Distribution: Volume of distribution: 0.13 L/kg. Plasma protein binding (active metabolite): 99% (mainly albumin). Metabolism: Rapidly converted to active metabolite A77 1726 in GI mucosa and the liver. Excretion: Via urine (approx 43% as glucuronides) and faeces (approx 48%). Elimination half-life (active metabolite): Approx 14-18 days.
Mild renal impairment. Patient w/ history of TB due to the possibility of reactivation of the infection. Monitoring Parameters Monitor BP and liver enzyme values prior to initiation and periodically during therapy.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Weltin Tablet 10s | TAB | ₹135.00 |
| Acebrobid 100 mg Capsule 10s | CAP | ₹90.00 |
| Acebrobid SR Tablet 10s | TAB | ₹184.80 |
| Acetec 10mg Capsule 10s | CAP | ₹341.00 |
| Acetec 25 mg Capsule 10s | CAP | ₹691.50 |
| Acotrust 100 mg Tablet 15s | TAB | ₹180.00 |
| Acrofy Lotion 50gm Tube | LOTION | ₹470.00 |
| Affen Plus Tablet 10s | TAB | ₹27.00 |
| Agna 10000 Capsule 10s | CAP | ₹212.00 |
| Agna 25000 Capsule 10s | CAP | ₹495.00 |
| Alfoo 10 mg Tablet 30s | TAB | ₹517.00 |
| Almont 10 mg Tablet 10s | TAB | ₹182.25 |
| Almont 5mg Chewable Tablet 10s | TAB | ₹100.30 |
| Ampilong DS Tablet 10s | TAB | ₹71.82 |
| Ampilong Tablet 10s | TAB | ₹37.22 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist